Dr. Karen Noblett, M.D., has been appointed as the new Chairperson of the Board. Dr. Noblett is Board Certified in OB/GYN and Female Pelvic Medicine and Reconstructive Surgery. She has a distinguished career in academic medicine. Dr. Noblett serves as Chief Medical Officer of Axonics, which was acquired by Boston Scientific for $3.4 bn in January 2024. She was the founding Chair and Professor of the Department of OB/GYN in the School of Medicine at the University of California, Riverside, from 2014-2017. She was also a professor in the OB/GYN Department and Fellowship and Division Director for Urogynecology at the University of California, Irvine, as well as the Interim Chief Medical Officer. Dr. Noblett completed her Master of Advanced Studies in Clinical Research at the University of California, San Diego, and has published over 50 peer-reviewed journal articles and authored multiple book chapters.
Joining the board alongside Dr. Noblett are Jane Kiernan and Eileen Duffy. Jane Kiernan brings over 30 years of executive and management leadership in healthcare, having held significant roles in both public and private companies. Jane holds a position alongside Dr. Noblett on the Board of Directors of Axonics. She is the co-founder of K2 Biotechnology Ventures and has previously served as the CEO of Salter Labs and on the Board of Directors of Nasdaq-listed American Medical Systems (AMS). She served as Global General Manager at Baxter International. Kiernan has a proven track record of driving growth and innovation in the healthcare sector and holds a B.S. degree in business from Southern Methodist University.
Eileen Duffy brings to the board over 25 years of global commercial experience in the Lifesciences and Medtech Industries, through executive leadership roles at Baxter International, and Aerogen, Ireland’s largest indigenous medical device company, She brings deep commercial experience and a proven track record of building and growing companies across therapeutic areas and geographies. Eileen currently serves on the Board of Directors of Sarnova, a Patricia Industries company. Eileen has also held various global senior executive leadership positions at Baxter International, where she worked with Jane Kiernan. She received her Master’s in Business Administration (MBA) from University College Dublin (Ireland) and holds a Diploma in Corporate Governance from The Corporate Governance Institute.
These new board members join AVeta Medical’s Founder, Paula Newell, and Co-Founder and CEO, Brian Ledwith, to expand the board and guide the company through its next phase of growth and commercialization.
